Position in ELVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,349,416
-$2,196,692 QoQ
Shares Held
322,156
-31.9% QoQ
Ownership
0.440%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 210 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. ELVN ranks #129 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in ELVN
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,349,416 | 322,156 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $18,546,108 | 473,115 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,652,941 | 237,204 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $5,368,707 | 262,272 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,801,470 | 189,505 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,167,279 | 211,752 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $2,953,034 | 131,246 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,110,388 | 121,785 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,536,647 | 65,753 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $303,832 | 17,273 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $314,140 | 22,698 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $241,645 | 17,690 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $556,907 | 27,286 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $906,900 | 41,411 | Shares | Defined | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||